448 related articles for article (PubMed ID: 23332903)
1. Long term follow-up of infliximab efficacy in pulmonary and extra-pulmonary sarcoidosis refractory to conventional therapy.
Russell E; Luk F; Manocha S; Ho T; O'Connor C; Hussain H
Semin Arthritis Rheum; 2013 Aug; 43(1):119-24. PubMed ID: 23332903
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effect of infliximab on refractory sarcoidosis.
Ørum M; Hilberg O; Krag S; Bendstrup E
Dan Med J; 2012 Dec; 59(12):A4535. PubMed ID: 23290282
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate as a single agent for treating pulmonary sarcoidosis: a single centre real-life prospective study.
Goljan-Geremek A; Bednarek M; Franczuk M; Puścińska E; Nowiński A; Czystowska M; Kamiński D; Korzybski D; Stokłosa A; Kowalska A; Wojda E; Sliwiński P; Burakowska B; Ptak J; Barańska I; Drygalska A; Małek G; Bestry I; Wesołowski S; Kram M; Górecka D
Pneumonol Alergol Pol; 2014; 82(6):518-33. PubMed ID: 25339562
[TBL] [Abstract][Full Text] [Related]
4. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement.
Baughman RP; Drent M; Kavuru M; Judson MA; Costabel U; du Bois R; Albera C; Brutsche M; Davis G; Donohue JF; Müller-Quernheim J; Schlenker-Herceg R; Flavin S; Lo KH; Oemar B; Barnathan ES;
Am J Respir Crit Care Med; 2006 Oct; 174(7):795-802. PubMed ID: 16840744
[TBL] [Abstract][Full Text] [Related]
5. The use of infliximab in cutaneous sarcoidosis.
Meyerle JH; Shorr A
J Drugs Dermatol; 2003 Aug; 2(4):413-4. PubMed ID: 12884466
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment with infliximab in patients with sarcoidosis.
Hostettler KE; Studler U; Tamm M; Brutsche MH
Respiration; 2012; 83(3):218-24. PubMed ID: 21811048
[TBL] [Abstract][Full Text] [Related]
7. Frequency of acute worsening events in fibrotic pulmonary sarcoidosis patients.
Baughman RP; Lower EE
Respir Med; 2013 Dec; 107(12):2009-13. PubMed ID: 24211131
[TBL] [Abstract][Full Text] [Related]
8. 18F-FDG PET in sarcoidosis: an observational study in 12 patients treated with infliximab.
Keijsers RG; Verzijlbergen JF; van Diepen DM; van den Bosch JM; Grutters JC
Sarcoidosis Vasc Diffuse Lung Dis; 2008 Dec; 25(2):143-9. PubMed ID: 19382534
[TBL] [Abstract][Full Text] [Related]
9. Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients.
Riancho-Zarrabeitia L; Calvo-Río V; Blanco R; Mesquida M; Adan AM; Herreras JM; Aparicio Á; Peiteado-Lopez D; Cordero-Coma M; García Serrano JL; Ortego-Centeno N; Maíz O; Blanco A; Sánchez-Bursón J; González-Suárez S; Fonollosa A; Santos-Gómez M; González-Vela C; Loricera J; Pina T; González-Gay MA
Semin Arthritis Rheum; 2015 Dec; 45(3):361-8. PubMed ID: 26092330
[TBL] [Abstract][Full Text] [Related]
10. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
Aringer M; Houssiau F; Gordon C; Graninger WB; Voll RE; Rath E; Steiner G; Smolen JS
Rheumatology (Oxford); 2009 Nov; 48(11):1451-4. PubMed ID: 19748965
[TBL] [Abstract][Full Text] [Related]
11. Infliximab for treating sarcoidosis patients, Portuguese experience.
Aguiar M; Marçal N; Mendes AC; Bugalho de Almeida A
Rev Port Pneumol; 2011; 17(2):85-93. PubMed ID: 21477572
[TBL] [Abstract][Full Text] [Related]
12. Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases.
Daïen CI; Monnier A; Claudepierre P; Constantin A; Eschard JP; Houvenagel E; Samimi M; Pavy S; Pertuiset E; Toussirot E; Combe B; Morel J;
Rheumatology (Oxford); 2009 Aug; 48(8):883-6. PubMed ID: 19423648
[TBL] [Abstract][Full Text] [Related]
13. The potential additional benefit of infliximab in patients with chronic pulmonary sarcoidosis already receiving corticosteroids: a retrospective analysis from a randomized clinical trial.
Judson MA; Baughman RP; Costabel U; Mack M; Barnathan ES
Respir Med; 2014 Jan; 108(1):189-94. PubMed ID: 24361164
[TBL] [Abstract][Full Text] [Related]
14. [Successful treatment with infliximab of a patient with refractory sarcoidosis].
Fouchier SM; Möller GM; Van Santen-Hoeufft M; Faber CG; Smeenk FW; Drent M
Ned Tijdschr Geneeskd; 2004 Dec; 148(49):2446-50. PubMed ID: 15626311
[TBL] [Abstract][Full Text] [Related]
15. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P
Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102
[TBL] [Abstract][Full Text] [Related]
16. Does tumour necrosis factor-alpha inhibitor infliximab induce histological resolution of pulmonary sarcoid granulomas?
Milman N; Andersen CB; Baslund B; Loft A; Iversen M
Clin Respir J; 2007 Dec; 1(2):106-13. PubMed ID: 20298289
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Tolerance of Anti-Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis: A French Study of 46 Cases.
Heidelberger V; Ingen-Housz-Oro S; Marquet A; Mahevas M; Bessis D; Bouillet L; Caux F; Chapelon-Abric C; Debarbieux S; Delaporte E; Duval-Modeste AB; Fain O; Joly P; Marchand-Adam S; Monfort JB; Noël N; Passeron T; Ruivard M; Sarrot-Reynauld F; Verrot D; Bouvry D; Fardet L; Chosidow O; Sève P; Valeyre D
JAMA Dermatol; 2017 Jul; 153(7):681-685. PubMed ID: 28564695
[TBL] [Abstract][Full Text] [Related]
18. Infliximab therapy in established rheumatoid arthritis: an observational study.
Voulgari PV; Alamanos Y; Nikas SN; Bougias DV; Temekonidis TI; Drosos AA
Am J Med; 2005 May; 118(5):515-20. PubMed ID: 15866254
[TBL] [Abstract][Full Text] [Related]
19. [TNFα blocking agents and sarcoidosis: an update].
Toussirot E; Pertuiset E
Rev Med Interne; 2010 Dec; 31(12):828-37. PubMed ID: 20510487
[TBL] [Abstract][Full Text] [Related]
20. Infliximab for the treatment of psoriasis in Greece: 4 years of clinical experience at a single centre.
Antoniou C; Stefanaki I; Stratigos A; Moustou E; Vergou T; Stavropoulos P; Avgerinou G; Rigopoulos D; Katsambas AD
Br J Dermatol; 2010 May; 162(5):1117-23. PubMed ID: 19906069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
